Schizophrenia
Schizophrenia can affect how a person perceives reality, thinks and feels, sometimes involving hearing voices or holding unusual beliefs.
CompletedNCT01639872
What is this study about?Researchers compared Clozapine and Risperidone to find out how the approaches affected cannabis use in people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including Garden GroveSchizophreniaMedication studyAges 18–55
- Countries
- United States
- Sponsor
- Dartmouth-Hitchcock Medical Center
WithdrawnNCT01448499
Official study titleClozapine Versus Amisulpride Versus Their Combination in the Treatment of Drug-resistant Schizophrenia Patients
This study was withdrawn before enrollment.
In Petah TikvaSchizophreniaMedication studyAges 18–65
- Countries
- Israel
- Sponsor
- Geha Mental Health Center
TerminatedNCT00169039
Official study titleClozapine Response and Biogenic Amines in Schizophrenia
This study ended early.
In Jamaica PlainSchizophreniaMedication studyAges 19–60
- Countries
- United States
- Sponsor
- Harvard Medical School (HMS and HSDM)
TerminatedNCT00169091
Official study titleClozapine or Haloperidol in First Episode Schizophrenia
This study ended early.
In Jamaica PlainSchizophreniaMedication studyAges 18–45
- Countries
- United States
- Sponsor
- Harvard Medical School (HMS and HSDM)
CompletedNCT02874482
Official study titleStudy of Cognitive and Emotional Factors Influencing the Visual Exploration Among Patients With Schizophrenia
This study has finished and is no longer accepting participants.
In LilleSchizophreniaObservational studyAges 18+
- Countries
- France
- Sponsor
- University Hospital, Lille
CompletedNCT07609953
Official study titleEffectiveness of Cognitive Behavioral Therapy as Adjunctive Therapy on Cognitive Function and Serum Brain-Derived Neurotrophic Factor Levels in Patients With Schizophrenia Receiving Risperidone Therapy
This study has finished and is no longer accepting participants.
In MakassarSchizophreniaMedication studyAges 20–50
- Countries
- Indonesia
- Sponsor
- Hasanuddin University
CompletedNCT01704833
This study has finished and is no longer accepting participants.
In New YorkSchizophreniaBehavioural studyAges 18–65
- Countries
- United States
- Sponsor
- Weill Medical College of Cornell University
CompletedNCT03217955
This study has finished and is no longer accepting participants.
Location not clearly listedSchizophreniaBehavioural studyAges 18–35
- Countries
- Sponsor
- Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
CompletedNCT01891929
Official study titleSpecific Cognitive Remediation for Schizophrenia (RECOS) and Sheltered Employment: a Multicentre Controlled Randomized Trial.
This study has finished and is no longer accepting participants.
Multiple locations, including BronSchizophreniaBehavioural studyAges 18–50
- Countries
- France
- Sponsor
- Hôpital le Vinatier
CompletedNCT01781923
Official study titleA Remediation Program for Children at High-Risk of Schizophrenia: 22q11.2 Deletion Syndrome
This study has finished and is no longer accepting participants.
In DurhamSchizophreniaBehavioural studyAges 11–17
- Countries
- United States
- Sponsor
- Duke University
WithdrawnNCT03407950
Official study titleCognitive Remediation Program for Hospitalized in the Long Term Patients With Deficit Schizophrenia : Impact on the Capacities of Autonomy
This study was withdrawn before enrollment.
In MontpellierSchizophreniaBehavioural studyAges 18–60
- Countries
- France
- Sponsor
- University Hospital, Montpellier